BLK vs BRK-B
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
BlackRock exhibits strong fundamental health with a Piotroski F-Score of 7/9 and a very conservative debt-to-equity ratio of 0.24. However, the stock is trading at a massive premium, with a current price of $1023.65 far exceeding both the Graham Number ($535.18) and the growth-based Intrinsic Value ($247.24). While revenue growth remains robust at 23.4%, a concerning divergence is evident as earnings growth has plummeted by 31.7% YoY. The combination of bearish insider activity and a 0/100 technical trend offsets the bullish analyst consensus.
The deterministic health profile is weak, highlighted by a Piotroski F-Score of 3/9, indicating deteriorating operational efficiency and profitability trends. While the company maintains a fortress balance sheet with a Debt/Equity ratio of 0.19 and a Current Ratio of 7.07, the stock is trading at a significant premium to its growth-based intrinsic value of $217.21. Negative YoY revenue and earnings growth, coupled with a bearish technical trend, offset the positive analyst sentiment and long-term historical performance.
Compare Another Pair
Related Comparisons
BLK vs BRK-B: Head-to-Head Comparison
This page compares BlackRock, Inc. (BLK) and Berkshire Hathaway Inc. (BRK-B) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.